Log In
Print this Print this

ocaratuzumab (AME-133v, LY2469298)

  Manage Alerts
Collapse Summary General Information
Company Mentrik Biotech LLC
DescriptionHumanized fc engineered mAb against CD20
Molecular Target CD20
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today